DEFA14A ·Filed Apr 24, 2026
Proxy solicitation materials
Actionable Insight • Neutral
This is a routine annual proxy filing with no material developments. Monitor the company's next 10-Q or 10-K filing for financial performance updates and any changes in guidance.
Final — all horizons settled through T+60d ⚠ clustered
AXSM ▲ +27.87% at T+60d
NEUTRAL call ✓ call won +27.87% · α vs SPY +23.09% · entry $187.40 → $239.62
T+1d
-1.28%
call -1.28% · α -0.80%
$185.00
settled 5mo ago
T+5d
+19.37%
call +19.37% · α +18.97%
$223.70
settled 5mo ago
T+20d
+24.97%
call +24.97% · α +20.02%
$234.20
settled 4mo ago
T+60d
+27.87%
call +27.87% · α +23.09%
$239.62
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Axsome Therapeutics is holding its 2026 annual meeting for shareholders to vote on director elections, auditor ratification, and executive compensation. This is a routine annual governance filing with no material financial or strategic changes disclosed.
Key Facts
- Annual shareholder meeting scheduled for June 5, 2026
- Voting on election of two directors: Mark Saad and Susan Mahony
- Ratification of Deloitte & Touche LLP as independent auditor
- Advisory vote on executive compensation
- No material financial data, strategic changes, or unexpected events disclosed
Financial Impact
No financial impact from this filing
Risk Factors
- None disclosed in this filing
- Routine governance risk associated with any shareholder vote
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-177613 |
| Document: 0001193125-26-177613-index-headers.html | 0001193125-26-177613 |
| Document: 0001193125-26-177613-index.html | 0001193125-26-177613 |
| Document: 0001193125-26-177613.txt | 0001193125-26-177613 |
23 reports for AXSM
83% Hit rate best @ T+60▲ +14.74%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Institutional Cluster | $214.66 $211.12 | ▼ −1.65% | ▲ +0.25% | $176.95 (−17.57%) |
Aug 10, 2026 7w ago | 8-K | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $176.95 (−19.89%) |
Aug 10, 2026 7w ago | Press Release | $220.89 $207.82 | ▼ −5.92% | ▼ −5.00% | $176.95 (−19.89%) |
Jul 15, 2026 11w ago | Press Release | $237.53 $214.66 | ▼ −9.63% | ▼ −11.97% | $176.95 (−25.51%) |
Jul 9, 2026 12w ago | Court Ruling | $248.95 $210.13 | ▼ −15.59% | ▼ −17.84% | $176.95 (−28.92%) |
Jul 7, 2026 12w ago | Press Release | $249.76 $211.04 | ▼ −15.50% | ▼ −16.84% | $176.95 (−29.15%) |
Jul 1, 2026 13w ago | 144 | $244.31 $234.64 | ▼ −3.96% | ▼ −3.54% | $176.95 (−27.57%) |
Jun 15, 2026 15w ago | Press Release | $253.40 $228.28 | ▼ −9.91% | ▼ −9.16% | $176.95 (−30.17%) |
Jun 12, 2026 16w ago | Insider Cluster | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $176.95 (−30.66%) |
Jun 11, 2026 16w ago | 144 | $255.17 $233.80 | ▼ −8.37% | ▼ −10.15% | $176.95 (−30.66%) |
Showing 10 of 23
US Market Status
Market Open — Closes in 2h 19m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access